| |
| |
|
| Insider
Information: |
Renger John |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,370 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$269,770 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,370 |
|
|
| Total
Value |
$269,770 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cerevel Therapeutics Holdings, I... |
CERE |
|
2024-02-07 |
6,370 |
2021-11-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-11-10 |
4 |
OE |
$3.50 |
$192,500 |
D/D |
55,000 |
55,000 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-11-10 |
4 |
AS |
$38.59 |
$2,192,187 |
D/D |
(55,000) |
0 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-15 |
4 |
OE |
$3.50 |
$87,500 |
D/D |
25,000 |
26,980 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-15 |
4 |
AS |
$30.02 |
$750,448 |
D/D |
(25,000) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-16 |
4 |
AS |
$32.50 |
$181,285 |
D/D |
(5,578) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-16 |
4 |
OE |
$3.50 |
$19,523 |
D/D |
5,578 |
7,558 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-17 |
4 |
OE |
$3.50 |
$24,927 |
D/D |
7,122 |
9,102 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-17 |
4 |
AS |
$32.50 |
$231,465 |
D/D |
(7,122) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-21 |
4 |
OE |
$3.50 |
$25,550 |
D/D |
7,300 |
9,280 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-21 |
4 |
AS |
$32.50 |
$237,250 |
D/D |
(7,300) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-23 |
4 |
AS |
$35.00 |
$205,582 |
D/D |
(5,873) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-23 |
4 |
OE |
$3.50 |
$20,556 |
D/D |
5,873 |
7,853 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-27 |
4 |
OE |
$3.50 |
$14,445 |
D/D |
4,127 |
6,107 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2021-12-27 |
4 |
AS |
$35.00 |
$144,445 |
D/D |
(4,127) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-02-09 |
4 |
OE |
$3.50 |
$87,500 |
D/D |
25,000 |
26,980 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-02-09 |
4 |
AS |
$30.00 |
$750,000 |
D/D |
(25,000) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-02 |
4 |
AS |
$30.00 |
$750,000 |
D/D |
(25,000) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-02 |
4 |
OE |
$3.50 |
$87,500 |
D/D |
25,000 |
26,980 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-09 |
4 |
OE |
$3.50 |
$105,000 |
D/D |
30,000 |
31,980 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-09 |
4 |
AS |
$32.50 |
$1,000,000 |
D/D |
(30,000) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-16 |
4 |
OE |
$3.50 |
$87,500 |
D/D |
25,000 |
26,980 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-16 |
4 |
AS |
$30.00 |
$750,005 |
D/D |
(25,000) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-18 |
4 |
AS |
$32.50 |
$650,004 |
D/D |
(20,000) |
1,980 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-18 |
4 |
OE |
$3.50 |
$70,000 |
D/D |
20,000 |
21,980 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Chief Scientific Officer |
• – – |
2022-03-29 |
4 |
OE |
$3.50 |
$35,000 |
D/D |
10,000 |
11,980 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
